The blue revolution is underway.
At a time when the major pharmaceutical companies are locked in fierce competition to develop ever more high-tech and expensive anti-cancer drugs, an unexpected hero emerges from the depths of medical history: methylene blue.
Dr Schwartz, physician and researcher, reveals the fascinating history and the promises of this forgotten drug. From its earliest uses as a dye to its applications against infectious diseases, the saga of methylene blue suggests it could play a leading role in the fight against cancer.
Cancer is a disease of metabolism and methylene blue has the power to normalise this metabolism. In combination with other active substances, methylene blue has already benefited many patients. It could also help patients with Alzheimer's, Parkinson's and other brain diseases.
By examining case studies, patient testimonies and the latest advances in clinical research, Dr Schwartz paints a future in which cancer could become a commonplace chronic disease. He calls for clinical trials to be carried out swiftly in the interests of patients.
Follow him on this captivating journey through science, history and medicine, and discover how the past offers hope for new victories in the fight against cancer.
Dr Laurent Schwartz
Laurent Schwartz is a French oncologist renowned for his innovative research into cancer, which he approaches from a metabolic and physical perspective. He is also the author of numerous scientific publications in the field of oncology.
Available immediately,
ready for shipment within 1-2 working days